Certara, Inc. Files 8-K on Officer/Director Changes

Ticker: CERT · Form: 8-K · Filed: Dec 11, 2025 · CIK: 1827090

Certara, INC. 8-K Filing Summary
FieldDetail
CompanyCertara, INC. (CERT)
Form Type8-K
Filed DateDec 11, 2025
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$0.01, $750,000, $6,500,000, $4,000,000, $8,000,000
Sentimentneutral

Sentiment: neutral

Topics: management-change, corporate-governance, filing

TL;DR

Certara's leadership team is changing, with new officers/directors elected and others departing.

AI Summary

Certara, Inc. filed an 8-K on December 11, 2025, reporting on events that occurred on December 9, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.

Why It Matters

This filing indicates potential shifts in Certara's leadership and governance structure, which could impact strategic direction and operational oversight.

Risk Assessment

Risk Level: medium — Changes in key personnel and potential shifts in compensatory arrangements can signal internal adjustments or strategic realignments that may affect the company's future performance.

Key Players & Entities

FAQ

Who are the specific directors or officers departing from Certara, Inc.?

The filing does not specify the names of the departing directors or officers, only that such departures are being reported.

Who has been elected as new directors or appointed as new officers at Certara, Inc.?

The filing indicates the election of directors and appointment of officers but does not name the individuals involved.

What are the details of the compensatory arrangements for certain officers mentioned in the filing?

The filing states that compensatory arrangements of certain officers are being reported, but the specific details are not provided in this summary.

What is the significance of the 'Financial Statements and Exhibits' item in this 8-K filing?

This indicates that accompanying financial statements and other relevant exhibits are being filed with the SEC as part of this report.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on December 9, 2025.

Filing Stats: 1,413 words · 6 min read · ~5 pages · Grade level 10.8 · Accepted 2025-12-11 06:00:54

Key Financial Figures

Filing Documents

02. Departure of Directors or Certain

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 11, 2025, Certara, Inc. (the "Company") announced the appointment of Jon Resnick to serve as the Company's Chief Executive Officer, effective as of January 1, 2026 (the "Start Date"), to succeed Dr. William F. Feehery who is departing from his role as the Company's Chief Executive Officer and as a member of the Company's Board of Directors (the "Board"), effective as of the close of business on December 31, 2025. The Company also announced the Board's appointment of Mr. Resnick to serve as a Class III member of the Board, effective as of the Start Date, with a term expiring at the Company's 2026 annual meeting of stockholders. Mr. Resnick, 53, has served as the President for the U.S. and Canada regional business of IQVIA Holdings Inc. ("IQVIA"), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, since July 2019. Prior to his current role, Mr. Resnick served as President of IQVIA's Real World Solutions business, which he led since the merger of IMS Health and Quintiles in 2016. Jon first joined IMS Health, a predecessor company to IQVIA, in 2002 within the consulting division and subsequently held several different European and U.S. leadership positions within the consulting and services and real-world businesses. Prior to IMS Health, Mr. Resnick worked for the U.S. Senate Committee on Finance, where he advised on healthcare policy and developed legislation around Medicare, Medicaid, and broader health care reform. Mr. Resnick holds an MBA from the Kellogg School of Management, Northwestern University and a BA in Political Science from Union College. There are no family relationships between Mr. Resnick and any of the directors or executive officers of the Company, and there are no transactions i

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Certara, Inc. dated December 11, 2025 announcing executive transition. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 11, 2025 CERTARA, INC. (Registrant) By: /s/ Daniel Corcoran Daniel Corcoran Senior Vice President and General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing